Hopefully we will soon get an update on the testing of their second prospective client concering PFAS treatment. PFAS is obviously big business and all over the news. A multi Billion $ market opportunity. BioLargo has the most effective and cost-efficient PFAS treatment solution. Plus homecourt advantage in Orange County and existing business relations with the US Army who have to clean up many of their sites. Future looks very bright imo. November 16, 2021 https://irdirect.net/prviewer/release_only/id/4939360 First PFAS testing successful - testing of water provided by the company's first prospective PFAS treatment client, a large municipality in southern California, has confirmed that BioLargo's PFAS treatment technology can remove all PFAS compounds of regulatory interest to below State and Federal standards. Additional testing to optimize the AEC underway. Testing with our second prospective client's water is slated to begin next week.
I have high hopes for the Ikigai pet oder product. According to LinkedIn profile "IKIGAI Holdings is a consumer brand developer of "Essential" and "Everyday" products that are designed to scale to over $100,000,000 USD in annual sales per product." BioLargo Strategic Partnership with Ikigai to Launch New Consumer Product Direct to Consumer Test Marketing is Successful WESTMINSTER, CA / ACCESSWIRE / November 30, 2021 https://www.biolargo.com/company-news BioLargo, Inc. (OTCQB:BLGO), a developer of sustainable cleantech technologies and full-service environmental engineering company, announced that it had received a "go decision" from its strategic partner, Ikigai Holdings, LLC, following positive results from the test-marketing phase of a new pet odor control product based on BioLargo's proprietary technology, branded "POOPH". The "go decision" indicates Ikigai's intent to expand television advertising with the goal to launch the product into big-box retailers, and formalizes their exclusive license to the product. Jordan Stanley, CPO, IKIGAI Chief Product Officer & Co-Founder at IKIGAI https://www.linkedin.com/in/jordan-stanley-cpo-ikigai-ba262617 IKIGAI Holdings (IKIGAI), a Nevada Limited Liability Company (LLC) is a consumer brand developer of "Essential" and "Everyday" products that are designed to scale to over $100,000,000 USD in annual sales per product. IKIGAI can select and nurture winning consumer product ventures with unparalleled efficiency. My co-founder, Jane Pak and I have over two decades in creating leading consumer brands with global consumer packaged goods (CPG) companies as a proven and trusted partner. IKIGAI has offices on the East and West coast with laboratories focused on sourcing, testing, vetting, and preparing innovative products for mass-market introduction.
December 8, 2021 2:30 PM BioLargo Begins Next Step in Preparing Garratt-Callahan Minimal Liquid Discharge System for Commercial Launch https://feeds.issuerdirect.com/news-release.html?newsid=6409552090350725
BioLargo, Inc. Discusses Development and Scale-Up of Its PFAS Treatment Technology and 2022 Commercial Plans With The Stock Day Podcast Phoenix, Arizona--(Newsfile Corp. - December 16, 2021) - The Stock Day Podcast welcomed BioLargo, Inc. (OTCQB: BLGO), a company that invents, develops, and commercializes innovative platform technologies to solve challenging environmental problems like PFAS contamination, wastewater treatment, and industrial odor and VOC control. President and CEO of BioLargo, Dennis P. Calvert, joined Stock Day host Everett Jolly for an interview. Jolly began by asking about BioLargo's consumer products strategic partnership with Ikigai Holdings. "Ikigai is a company that is focused on launching consumer products," explained Calvert. "The partners at Ikigai have launched at least five blockbuster products in their careers," he said, adding that they are "experts in the art of launching products that can build into a national brand." He added, "We have bargained to be the supply chain partner. So, we're wholesaling our product, earning a royalty on the technology, and then participating in a minority way on the exit." Jolly then asked about the progress of BioLargo's Garratt-Callahan partnership. "Garratt-Callahan is the largest privately held water [treatment] company in America," said Calvert. "We joined them as a technical expert to bring forth engineering and science to develop a product according to a design that they had created," he explained. "That product is being tested now," said Calvert. "We're hoping to launch very early in 2022." The conversation then turned to the commercialization of BioLargo's technology that eliminates per- and polyfluoroalkyl substances (PFAS), a class of water contaminants of rising concern because of their ubiquity in water around the world and their long-term health effects. "The Biden administration has listed [PFAS] as one of the top environmental issues of the decade," said Calvert. "We have a device and expertise that provides selective extraction [of PFAS] … [It generates] 1/1000 the waste that's created for disposal of the competition." The company hopes to get its PFAS treatment technology, called the Aqueous Electrostatic Concentrator, commercialized in 2022 in part by partnering with established players in the water treatment industry. "These projects could range [from] half a million all the way up to [the] fifteen million dollar range," Calvert explained. "I think this is a huge opportunity for BioLargo to create value for our shareholders, so we are very excited." https://audioboom.com/posts/7998255...-its-pfas-treatment-technology-and-2022-comme
Thursday, 23 December 2021 BioLargo’s PFAS Removal System Achieves Total Elimination of Multiple PFAS Compounds in Testing with Client Water https://biolargo.blogspot.com/2021/12/biolargos-pfas-removal-system-achieves.html
Companies Race To Develop Solutions to Eradicate Pervasive PFAS January 10, 2022 https://www.benzinga.com/markets/pe...develop-solutions-to-eradicate-pervasive-pfas ... BioLargo Inc. invents, develops and commercializes innovative platform technologies to solve challenging environmental problems sustainably and affordably. The company has previously developed eco-friendly technologies for air quality control and water disinfection. BioLargo is now commercializing a new proprietary technology that eliminates PFAS from water. ...
Interview starts at 1h 44m Benzinga All Access: Growth Companies For 2022 January 14, 2022 FEATURED GUESTS: Ronen Luzon, Founder & CEO, My Size (MYSZ) Adi Zuloff-Shani, CTO, Scisparc (SPRC) Scott Kaufman, CEO, Creek Road Miners (CRKR) Dan Sztybel, CEO, Save Foods (SVFD) Dennis Calvert, CEO, BioLargo (BLGO) Mike Ferguson, President & CEO, Gensource Potash (AGCCF)
Biolargo $BLGO - Pennystock with Industry leading clean water and clean air tech. January 10,2022 This is one of my favorite OTC plays. BLGO has industry leading PFAS eliminating tech. Infrastructure bill allocated 10 billion to PFAS remediation. Their odor eliminating product "pooph" is being sold worldwide. They focus on sustainable solutions for environmental problems.
GREEN PLANET MICROCAPS ESG MICROCAP SPECIALISTS Our treasure chest is filled with microcap companies that have innovative solutions to address climate change and to help restore our planet’s balance back to a green healthy environment and to make life better See our promising young companies with world-changing solutions that also have great potential for remarkable growth BioLargo Shareholders Could Clean Up Big with Trillion Dollar Environmental Solutions Biden plan on removing PFAS from water and the environment is high priority for the new administration - $10 Billion in Federal spending dedicated to PFAS removal Rosa Gwinn, PFAS leading expert for AECOM, gave a staggering figure for the total cost of global PFAS clean-up - Up to a trillion dollars worldwide BioLargo has developed what appears to be the leading solution for PFAS removal that is low-cost, high-efficacy with low carbon footprint that is called the AEC, Aqueous Electrostatic Collector Testing at the University of Tennessee in Knoxville showed that BioLargo’s AEC PFAS Removal system removed over 99.995% of PFAS in a single pass such that less than one out of 50,000 PFAS molecules was able to penetrate the system BioLargo has agreed to install the AEC in pilot studies with large industry users that could lead to extraordinary revenues if trials are successful AOS broad spectrum water treatment system is low-cost, high-impact, and is being delivered to large users for pilot projects that could lead to extraordinary revenues Disruptive odor control CupriDyne Clean being adopted by biggest waste management companies in world and is now being launched by world-leading consumer blockbuster IKIGAI as “POOPH” World class environmental expert engineering division provides turnkey solutions for big industries Disruptive disinfection products already approved 510K being readied for giant healthcare industry Revenues have been setting record growth with very large potential for short and long term Convertible debt is gone removing potential overhang selling from share market trading https://richardacavalli.wixsite.com/greenplanetmicrocaps/biolargo-environmental
January 24, 2022 BioLargo AEC Featured in Treatment Plant Operator Magazine BioLargo’s Aqueous Electrostatic Concentrator, the company’s treatment solution to effectively and affordably remove per- and polyfluoroalkyl substances from water, has been featured in a prominent water treatment industry publication, Treatment Plant Operator (TPO). The article, which features an interview with BioLargo CEO Dennis Calvert and Director of Strategic Marketing and Business Development Tonya Chandler, does a deep dive on why the AEC is set to disrupt the PFAS treatment market. Download your copy of the article here: https://www.biolargoengineering.com/wp-content/uploads/2022/01/TPO0222-Technology-Deep-Dive.pdf
Tuesday, 25 January 2022 BioLargo PFAS treatment system highlighted in EPA report https://biolargo.blogspot.com/2022/01/biolargo-pfas-treatment-system.html BioLargo's innovative treatment system that removes per- and polyfluoroalkyl substances (PFAS) from water effectively and affordably has been highlighted as an emerging PFAS treatment technology in a new report from the EPA. Link to the report here: https://www.epa.gov/system/files/do...dy_preliminary-2021-report_508_2021.09.08.pdf
According to the interview BioLargo will get 20% on exit of Pooph sale. The ongoing campaign “exceeds all expectations”. The last company Ikigai built sold for $1/2 Billion. Plus PFAS is obviously big business. https://www.pooph.com/ BioLargos presentation starts at 1 hour ONE2ONE Virtual Investor Forum - Tuesday January 25th, 1pm EST
The word is now spreading fast in the water treatment industry concerning BioLargos's cutting edge PFAS treatment solution... A Modular, Compact Unit Uses the Polar Behavior of PFAS Molecules to Optimize Removal February 2022 Appeared in print as "PFAS — AN INNOVATIVE TREATMENT" https://www.tpomag.com/editorial/20...ehavior-of-pfas-molecules-to-optimize-removal
Market cap of $70 million is way too low imo considering the huge business potential for PFAS. Good times ahead.
North Carolina Middle School Students Test for PFAS 7th Graders test Wilmington, NC for per- and polyflouroalkyl substances for science fair project Feb 01, 2022 https://www.wwdmag.com/contaminants/north-carolina-middle-school-students-test-pfas ........ BioLargo inc. answered Travis Loops appeal. BioLargo is a Life Science company based in Westminster, California. Its focus is to invent, develop, and commercialize innovative platform technologies to solve challenging environmental problems. The BioLargo CEO Dennis Calvert read the post on LinkedIn and knew that the company wanted to help share this awareness of PFAS and foster the learning of water awareness in the next generation. BioLargo reached out to Travis with the offer to help. “We are always looking for ways to engage in the community and promote scientific research and development in our younger generations,” Calvert said. “Our motto is ‘we make life better’, and to do that we have to keep the next generation interested in environmental issues.” BioLargo is paving the way to finding better solutions for PFAS removal from drinking water streams. Partnering with the University of Tennessee, the company answered a call from the U.S. EPA, and through the help of a federal grant, developed new technology for PFAS removal from water. It worked with the University of Tennessee to come up with a measurement tool to test for PFAS fate in the system to ensure removal. The U of T’s skilled technicians also honed a testing method that allowed for lower detection limits, coming closer to the extremely low tolerance limits the EPA is aiming to institute. ........
Excellent write-up on BioLargo''s potential 3 Products Behind The Rise of This Clean-Water Tech Co. Source: PennyQueen (2/1/22) https://www.streetwisereports.com/a...ind-the-rise-of-this-clean-water-tech-co.html ... BioLargo has a market cap of a mere $68 million, and yet it is becoming a leading innovator in multi-billion-dollar industries. While it may be a penny stock now, I think BioLargo stands a good chance of moving up to the big boards naturally in the next two to three years. ... BioLargo's AEC system passes water through an electrochemical field and takes advantage of the PFAS molecule’s polarity to selectively capture the hazardous material on a membrane. Traditional activated carbon filters create 1,000 times the hazardous waste as the AEC system and this hazardous waste must be handled and disposed of appropriately. A recent BioLargo press release showed that they were able to achieve total elimination [in technical terms below ‘non-detect’] of multiple PFAS compounds in testing with a large municipality in Southern California. Tests have shown that the AEC can treat 1,000,000 gallons of highly contaminated water with little waste material at a very low cost. This is massive proof of concept!
BioLargo, Inc. Discusses Progress of Key Partnerships and its PFAS Treatment Technology with The Stock Day Podcast 3. Feb., 8:42 PM https://audioboom.com/posts/8024583...ps-and-its-pfas-treatment-technology-with-the Phoenix, Arizona--(Newsfile Corp. - February 3, 2022) - The Stock Day Podcast welcomed BioLargo, Inc. (OTCQB: BLGO), a company that invents, develops, and commercializes innovative platform technologies that solve challenging environmental problems like PFAS contamination, advanced water treatment, and industrial odor and VOC control. BioLargo President and CEO Dennis P. Calvert joined Stock Day host Everett Jolly. "What makes BioLargo unique in the clean technology and environmental space?" asked Jolly to start the interview. "It's all about sustainable environmental solutions, and we like to focus on big problems with huge markets," Calvert explained. "Commercial opportunities are expanding quickly, so we're really facing an extraordinary growth opportunity." Jolly then asked about BioLargo's recent partnerships and their significance. Calvert explained that once their innovative technologies were developed, partnerships are necessary to achieve meaningful commercialization. "Once you're there, you partner your way to success," said Calvert. Calvert expanded by using their partnership with Garratt-Callahan as an example. "Garratt-Callahan is the largest privately-held water [treatment] company in North America," he said. Our companies have been working together on a new 'minimal liquid discharge' product for industrial facilities. "The goal for that partnership is to sell about 30 to 50 units [in the first year that it launches]." Calvert went on to talk about Ikigai Holdings, LLC, with whom BioLargo has partnered to launch a pet odor control product into the consumer market. "Ikigai is composed of experts in the brand-building business [who have] launched numerous products over their careers," he said. "Backed with venture capital, [they are] focused on the idea of exploiting their special talent, which is building brands, and they selected our pet odor control product as a platform on which to build their business." "They have a big vision of a billion dollar per year brand," he continued. "We make a manufacturer's margin, as well as a 6% royalty on the technology, and 20% of the exit," said Calvert. "This is a great deal." Jolly then asked Calvert about their technology that removes per- and polyfluoroalkyl substances (PFAS), also known as toxic 'forever chemicals', from water. "Our solution [the BioLargo AEC] is a low cost, low environmental impact solution," said Calvert. "These [PFAS] chemicals have been linked to adverse health effects," he explained. "It accumulates in your body, in the earth, it is everywhere." He then explained that the AEC's most important advantage over competing technologies is that it produces less than 1/1000 the PFAS-laden solid waste product compared to competitors while remaining economical and effective. "Who are you targeting?" asked Jolly. "We are working with one of the largest municipal water districts in the industry," said Calvert. "We are doing work with supply chain partners that serve military bases," he added. "We are also working in the early stages with the mining field," said Calvert, adding that the company is working on developing commercial trials in each of those markets. "Do you think this is a good time for companies to get involved with environmental technology companies like BioLargo?" asked Jolly. "The world is becoming smarter and smarter about the danger of these pollutants," said Calvert. "We have great technology and people that make it work, and we love our customers." To close the interview, Calvert discussed the significance of BioLargo's potential as they continue to experience growth within the clean technology space and bring their environmental solutions to market.
February 17, 2022 2:30 PM BioLargo Provides Progress Report on Major Growth Catalysts https://feeds.issuerdirect.com/news-release.html?newsid=8829811365706826
BioLargo says current projects are “major growth catalysts,” as it shares updates with investors 18 February 2022 BioLargo Inc CEO Dennis Calvert joined Proactive's Stephen Gunnion with update on three key projects that he says are major growth catalysts for the company. Calvert telling Proactive that BioLargo's disruptive solutions have the potential to build significant value for the company and its shareholders, resulting in increased attention from the market.
